Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes

ανά Dei Cas, Alessandra, Spigoni, Valentina, Cito, Monia, Aldigeri, Raffaella, Ridolfi, Valentina, Marchesi, Elisabetta, Marina, Michela, Derlindati, Eleonora, Aloe, Rosalia, Bonadonna, Riccardo C., Zavaroni, Ivana
Τόπος έκδοσης Cardiovasc Diabetol (2017)